Cutera, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 04, 2022 at 04:01 pm EDT
Share
Cutera, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 64.22 million compared to USD 58.59 million a year ago. Net loss was USD 47.28 million compared to net income of USD 7.75 million a year ago. Basic loss per share from continuing operations was USD 2.53 compared to basic earnings per share from continuing operations of USD 0.43 a year ago. Diluted loss per share from continuing operations was USD 2.53 compared to diluted earnings per share from continuing operations of USD 0.39 a year ago.
For the six months, revenue was USD 122.24 million compared to USD 108.26 million a year ago. Net loss was USD 62.42 million compared to net income of USD 7.39 million a year ago. Basic loss per share from continuing operations was USD 3.39 compared to basic earnings per share from continuing operations of USD 0.41 a year ago. Diluted loss per share from continuing operations was USD 3.39 compared to diluted earnings per share from continuing operations of USD 0.4 a year ago.
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Companyâs Cutera Core segment consists of the Companyâs systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Companyâs AviClear segment consists of the AviClear business. The Companyâs acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
CUTERA, INC. 
